Afya Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Afya is forecast to grow earnings and revenue by 15.2% and 10.1% per annum respectively. EPS is expected to grow by 19.5% per annum. Return on equity is forecast to be 19.7% in 3 years.

Anahtar bilgiler

15.2%

Kazanç büyüme oranı

19.5%

EPS büyüme oranı

Consumer Services kazanç büyümesi26.0%
Gelir büyüme oranı10.1%
Gelecekteki özkaynak getirisi19.7%
Analist kapsamı

Good

Son güncelleme01 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Investors Holding Back On Afya Limited (NASDAQ:AFYA)

Nov 03
Investors Holding Back On Afya Limited (NASDAQ:AFYA)

Returns At Afya (NASDAQ:AFYA) Are On The Way Up

Oct 18
Returns At Afya (NASDAQ:AFYA) Are On The Way Up

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Aug 29

Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Aug 29
Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Aug 15
Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Jul 17
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 20
Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Afya's Results Are Improving And The Market Is Undervaluing It

Jun 06

Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

May 14
Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

AFYA: Mr Market Is Mistaken

Apr 29

Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Apr 27
Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Apr 09
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Is Performing Well And Is A Buy

Mar 19

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Mar 17
Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Feb 10
Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Jan 21
Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Jan 03
Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Dec 07
These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Nov 02
Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Sep 20
What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Aug 17
Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Aug 23

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Jul 28

Afya: Margin And Organic Growth Struggles Remain Top Of Mind

Apr 14

Afya On A Grey Price Area

Dec 25

Afya: The Longer-Term Growth Story Remains Intact

Sep 19

Afya to acquire UNIGRANRIO for R$700M

May 27

Here's Why I Think Afya (NASDAQ:AFYA) Is An Interesting Stock

Apr 04
Here's Why I Think Afya (NASDAQ:AFYA) Is An Interesting Stock

Is Afya Limited's (NASDAQ:AFYA) ROE Of 11% Impressive?

Mar 09
Is Afya Limited's (NASDAQ:AFYA) ROE Of 11% Impressive?

Is Afya (NASDAQ:AFYA) Using Too Much Debt?

Feb 16
Is Afya (NASDAQ:AFYA) Using Too Much Debt?

A Look At The Intrinsic Value Of Afya Limited (NASDAQ:AFYA)

Jan 29
A Look At The Intrinsic Value Of Afya Limited (NASDAQ:AFYA)

The Trends At Afya (NASDAQ:AFYA) That You Should Know About

Jan 12
The Trends At Afya (NASDAQ:AFYA) That You Should Know About

What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 24
What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Afya BOD approves share buyback program

Dec 23

Afya reports Q3 results

Dec 03

Is Afya Limited's (NASDAQ:AFYA) 10% ROE Strong Compared To Its Industry?

Dec 03
Is Afya Limited's (NASDAQ:AFYA) 10% ROE Strong Compared To Its Industry?

Kazanç ve Gelir Büyüme Tahminleri

NasdaqGS:AFYA - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (BRL Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20263,9978651,2271,3766
12/31/20253,6757621,1311,1597
12/31/20243,2896309299507
6/30/20243,0675538931,173N/A
3/31/20242,9704788381,130N/A
12/31/20232,8763867981,044N/A
9/30/20232,7303557591,024N/A
6/30/20232,587337667953N/A
3/31/20232,473356606897N/A
12/31/20222,329374547844N/A
9/30/20222,243352495818N/A
6/30/20222,117329430738N/A
3/31/20221,891245434730N/A
12/31/20211,719223354631N/A
9/30/20211,566235387591N/A
6/30/20211,421257329503N/A
3/31/20211,323300300449N/A
12/31/20201,201292234372N/A
9/30/20201,077285283377N/A
6/30/2020974257234380N/A
3/31/2020878212210343N/A
12/31/2019751154178299N/A
9/30/2019636128137247N/A
6/30/2019522106119156N/A
3/31/201941711093120N/A
12/31/2018334865980N/A
12/31/201721645N/A40N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: AFYA's forecast earnings growth (15.2% per year) is above the savings rate (2.5%).

Kazançlar ve Piyasa: AFYA's earnings (15.2% per year) are forecast to grow slower than the US market (15.4% per year).

Yüksek Büyüme Kazançları: AFYA's earnings are forecast to grow, but not significantly.

Gelir ve Pazar: AFYA's revenue (10.1% per year) is forecast to grow faster than the US market (8.9% per year).

Yüksek Büyüme Geliri: AFYA's revenue (10.1% per year) is forecast to grow slower than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: AFYA's Return on Equity is forecast to be low in 3 years time (19.7%).


Büyüyen şirketleri keşfedin